Hepatocyte Growth Factor-Like Protein is a Positive Regulator of Early Mammary Gland Ductal Morphogenesis
| Autor: | Sasha J. Ruiz-Torres, Abby L. Johnson, Devikala Gurusamy, Dana A. Smith, Susan E. Waltz |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2014 |
| Předmět: |
STAT3 Transcription Factor
medicine.medical_specialty Embryology Stromal cell Mammary gland Morphogenesis Receptor tyrosine kinase Article Mice Mammary Glands Animal Internal medicine Proto-Oncogene Proteins medicine Animals RNA Messenger STAT3 Mice Knockout biology Hepatocyte Growth Factor Macrophages Receptor Protein-Tyrosine Kinases Epithelial Cells medicine.anatomical_structure Endocrinology Tumor progression Hepatocyte Growth Factor-Like Protein biology.protein Cancer research Hepatocyte growth factor Female medicine.drug Developmental Biology Signal Transduction |
| Popis: | The Ron receptor tyrosine kinase regulates multiple cellular processes and is important during mammary gland development and tumor progression. Hepatocyte growth factor-like protein [HGFL] is the only known ligand for the Ron receptor and recent studies have identified major roles for HGFL during breast cancer metastasis. Understanding the functional importance HGFL during mammary gland development will provide significant insights onto its contribution during tumor development and metastasis. In this study, we assessed the role of HGFL during postnatal mammary gland development using mice that were either proficient [HGFL +/+] or deficient [HGFL-/-] for HGFL. Postnatal ductal morphology and stromal cell associations were analyzed at multiple time points through puberty until adulthood. HGFL deficiency resulted in several mammary gland developmental defects including smaller terminal end buds [TEBs], significantly fewer TEBs, and delayed ductal outgrowth during early puberty. Additionally, HGFL deficient animals exhibited significantly altered TEB epithelial cell turnover with decreased proliferation and increased apoptosis coupled with decreased TEB diameter. Macrophage recruitment to the TEBs was also significantly decreased in the HGFL-/- mice compared to controls. Moreover, the levels of STAT3 mRNA as well as the phosphorylation status of this protein were lower in the HGFL-/- mammary glands compared to controls. Taken together, our data provide the first evidence for HGFL as a positive regulator of mammary gland ductal morphogenesis by controlling overall epithelial cell turnover, macrophage recruitment, and STAT3 activation in the developing mammary gland. With a function in early mammary gland development, HGFL represents a potential target for the development of novel breast cancer therapies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|